Ani Pharmaceuticals Inc (ANIP)
SBC to Revenue
8.12%
Quarterly · Period ending:

ANIP SBC to Revenue
Latest reported8.12%period ending
Latest reported8.12%period ending
ANIP Quarterly SBC/Revenue (0.00% → 8.12%)
Latest values, visible window
High-resolution chart · PNG
ANIP sbc to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SBC to Revenue |
|---|---|
| 8.1178% | |
| 0% | |
| 3.9537% | |
| 4.2539% | |
| 4.5427% | |
| 4.4987% | |
| 3.7051% | |
| 5.0454% | |
| 5.6969% | |
| 5.0455% | |
| 4.2695% | |
| 4.1296% | |
| 4.5038% | |
| 4.0623% | |
| 3.9657% | |
| 4.6158% | |
| 5.0856% | |
| 5.0204% | |
| 4.8712% | |
| 5.3937% | |
| 5.8488% | |
| 3.428% | |
| 4.1798% | |
| 4.498% | |
| 11.8341% | |
| 4.87% | |
| 0% | |
| 4.8113% | |
| 4.7703% | |
| 3.2333% | |
| 3.2002% | |
| 3.5402% | |
| 3.77% | |
| 2.9624% | |
| 3.0072% | |
| 3.0625% | |
| 4.0367% | |
| 3.784% | |
| 3.6121% | |
| 3.5432% | |
| 7.0747% | |
| 5.3758% | |
| 6.3155% | |
| 5.6079% | |
| 5.2726% | |
| 3.0214% | |
| 3.3465% | |
| 3.9857% | |
| 29.7728% | |
| 0.4312% | |
| 0.3088% | |
| 0.0383% | |
| 69.4494% | |
| 100.5199% | |
| -6.4467% | |
| 244.6047% | |
| 247.6917% | |
| 274.5851% | |
| 96.4913% | |
| 166.9522% | |
| 284.6895% | |
| 615.4298% | |
| 168.4707% | |
| 633.8256% | |
| 0% | |
| 8.9905% | |
| 28.9468% | |
| 2,908.8734% | |
| 265.0148% | |
| 491.201% | |
| 0% | |
| 0% | |
| 0% | |
| 567.5264% | |
| 0% | |
| 0% | |
| 167.3372% | |
| 436.2907% | |
| 0% | |
| -35.0639% | |
| -66.31% | |
| 1,014.4345% | |
| 362,479.5042% | |
| 0% | |
| 0% | |
| -1,403.801% | |
| 0% | |
| 0% | |
| 0% | |
| 4,017.4412% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0.9776% | |
| 0% | |
| 0% | |
| 0% | |
| -1.001% | |
| 0% |